BC Platforms to expand Genotyping services across Europe

BC Platforms, a world leader in genomic data management and analytics, on 6 Dec 2019 announced that it has formed a partnership with Life &Brain Genomics, a division of Life & Brain GmbH. Life & Brain Genomics is one of the leading European service providers for array-based omics analyses, supporting its customers from academia, industry and the healthcare sector with innovative products and scientific expertise from project planning to data analysis. The partnership will leverage BC Platforms’ high performing solutions to securely integrate and analyse genetic array data to support Life & Brain’s Genomics customer offerings.

BC Platforms will use a combination of its solutions, including BC|GENOME, BC|PIPE and BC|SAMPLE, to streamline Life & Brain’s genetic array data input whilst ensuring quality control and sample management. This system will accelerate data delivery through process automation and interoperability. All of BC Platforms’ modules are interoperable, designed to be integrated with other IT systems and instruments such as Illumina iScan, allowing our customers to spend more time on analysis and thereby increase turnaround.

Prof Markus Nöthen, CEO of Life & Brain, commented; "We are delighted to be working with BC Platforms, a leader in genomic data management and analytics, who in our opinion has the best bioinformatics pipeline for automated genotyping workflows. This partnership helps us to meet increased demand from our European customers that require our services for data production with high quality and timely delivery. BC Platforms’ solution allows us to spend more time on revenue-generating tasks to the benefit of our customers and their patients.’

Nino da Silva, EVP EMEA-APAC, commented; "We are pleased to be selected to support Life & Brain Genomics by providing automated and streamlined processes for the production of their data. Life & Brain is one of the leading service providers in the whole of Europe and we look forward to supporting them with their genotyping services and also in supporting them to expand into new services in this field."